参考文献/References:
[1] 李十红,张宇军,沈雁霞,等.中国成人血脂异常防治指南(2016年修订版)更新后对北京延庆地区医生血脂异常防治知识调查分析[J].中国循证心血管医学杂志,2017,9(9):1062-1065.
[2] Adi D,Abuzhalihan JL,Wang YH,et al.IDOL gene variant is associated with hyperlipidemia in Han population in Xinjiang China[J].Sci Reports,2020,10(1):142-148.
[3] 章龙平.他汀类药物药理作用、临床应用及不良反应的研究进展[J].内科,2015,10(1):103-106.
[4] 杨 珍,马晓芝,马 祎,等.他汀类降脂药物与其他药物联合应用所致药物不良反应分析[J].内科,2018,13(2):181-184.
[5] 汪卫东,李 炜,刘新平,等.2001-2013年邯郸市他汀类药物不良反应分析[J].现代药物与临床,2014,29(5):536-540.
[6] Von MC,Jensen LJ,Snel B,et al.String:Known and predicted protein-protein associationsintegrated and transferred across organisms[J].Nucleic Acids Research,2005,33(1):433-437.
[7] Cui Q,Zhang YL,Ma YH,et al.A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke[J].Journal Ethnopharmacol,2020,257(14):112-129.
[8] Zhou Y,Zhou B,Pache L,et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J].Nat Commun,2019,10(1):152-153.
[9] 李 婧,张英秀,苏学燕,等.基于网络药理与分子对接技术的乌梅清润茶防治咽喉疾病作用机制研究[J].西南民族大学学报:自然科学版,2021,47(3):267-278.
[10] 杨 艳,马 俊.中医药治疗血脂异常的研究进展[J].世界最新医学信息文摘,2019,19(20):74-77.
[11] 杜 林.化痰祛瘀法治疗血脂异常的临床研究[J].长春中医药大学学报,2010,26(6):839-840.
[12] 林少英.健康体检成人血脂水平流行现状及影响其水平的相关因素分析[J].现代诊断与治疗,2019,30(11):1921-1923.
[13] 姚 璠,王 莹,冷向阳,等.中医药防治血脂异常及动脉粥样硬化的进展研究[J].吉林中医药,2020,40(10):1282-1285.
[14] Nelson RH.Hyperlipidemia as a risk factor for fardiovascular disease[J].Primary Care:Clinics in Office Practice,2013,40(1):195-211.
[15] 胡书云,韩 冰,王金玲.中药汤剂在治疗高血脂症中的应用效果评估[J].四川中医,2019,37(6):219-221.
[16] 周红军,郭 巍.中药治疗高血脂症的临床研究进展[J].现代中西医结合杂志,2011,20(20):2592-2594.
[17] 刘桂霞,冯 骉,李艾容.补阳还五汤加味治疗高脂血症50例临床分析[J].吉林大学学报:医学版,2009,35(6):1171.
[18] 杨孝华.参芪五子降脂汤治疗高血脂症120例临床疗效分析[J].临床和实验医学杂志,2015,14(15):1272-1275.
[19] 熊 英.决明子蒽醌苷防治高脂血症实验研究[J].湖北中医杂志,2015,37(1):18-19.
[20] Shindoh J,Hasegawa K,Inoue Y,et al.Risk factors of postoperative recurrence and adequate surgical approach to improve long term outcomes of hepatocellular carcinoma[J].HPB(Oxford),2013,15(1):31-39.
[21] 袁向飞,谢俊木子,谭晓华.大黄及其有效成分抗肿瘤的研究进展[J].中国中西医结合外科杂志,2018,24(3):363-366.
[22] 刘 静,王 丽.大黄素的研究进展[J].中国药房,2014,25(35):3351-3354.
[23] 史永平,孔浩天,李昊楠,等.栀子的化学成分、药理作用研究进展及质量标志物预测分析[J].中草药,2019,50(2):281-289.
[24] 谢志忻,钟 云,黄丽萍,等.栀子的降脂作用与安全性评价研究[J].中药药理与临床,2014,30(5):105-108.
[25] Oliveira H,Cai X,Zhang Q,et al.Gastrointestinal absorptionantiproliferative and anti-inflammatory effect of the major carotenoids of gardenia jasminoides ellis on cancer cells[J].Food Funct,2017,8(4):1672-1679.
[26] Chen Y,Zhang H,Li YX,et al.Crocin and geniposide profiles and radical scavenging activity of gardenia fruits(gardenia jasminoides ellis)from different cultivars and at the various stages of maturation[J].Fitoterapia,2010,81(4):269-273.
[27] Dludla PV,Nkambule BB,Jack B,et al.Inflammation and oxidative stress in an obese state and the protective effects of gallic acid[J].Nutrients,2018,11(1):1-8.
[28] Cavieres V,Valdes K,Moreno B,et al.Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia:Role for nitric oxide and interleukin-6[J].Am Journal Cardiovasc Dis,2014,4(3):114-122.
[29] Takeuchi M.Serum levels of toxic AGEs(TAGE)may be a promising novel biomarker for the onset/progression of lifestyle-related diseases[J].Diagnostics,2016,6(2):23.
[30] Huang D,Li T,Li X,et al.HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression[J].Cell Rep,2014,8(6):1930-1942.
[31] Ha CH,Kim S,Chung J,et al.Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis[J].Int Journal Mol Med,2013,32(2):373-380.
相似文献/References:
[1]丁 维,钟立仁,张海波,等.丹参酮ⅡA磺酸钠对高脂血症勃起功能障碍大鼠Nrf2/HO-1通路及勃起功能的影响*[J].陕西中医,2020,(11):1520.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.002]
DING Wei,ZHONG Liren,ZHANG Haibo,et al.Sodium tanshinone ⅡA sulfonate ameliorates erectile function in hyperlipidemia ED rats by up-regulating Nrf2/HO-1[J].,2020,(12):1520.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.002]
[2]刘小微,李娟娥,姜小帆,等.丹蒌片对载脂蛋白E基因敲除小鼠血脂及AMPK/SREBP通路的影响[J].陕西中医,2021,(11):1531.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.008]
[3]吴巧敏,刘金凤,汪艳丽,等.刘如秀教授论治血浊经验[J].陕西中医,2022,(5):624.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.019]
WU Qiaomin,LIU Jinfeng,WANG Yanli,et al.Professor LIU Ruxiu's experience in treating hyperlipidemia[J].,2022,(12):624.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.019]
[4]周颖丽,罗 茜,尹紫薇,等.郭志华治疗高脂血症临床经验[J].陕西中医,2023,(6):781.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.023]
ZHOU Yingli,LUO Xi,YIN Ziwei,et al.Guo Zhihua's clinical experience in the treatment of hyperlipidemia[J].,2023,(12):781.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.023]
[5]王淑平,李艳芳,孙 雪,等.茵陈蒿汤联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症疗效及Th17/Treg失衡对妊娠结局的影响[J].陕西中医,2023,(8):1074.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.017]
WANG Shuping,LI Yanfang,SUN Xue,et al.Efficacy of Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of ICP and the effect of Th17/Treg imbalance on pregnancy outcome[J].,2023,(12):1074.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.017]
[6]周 芳,陈文明,陈新宇,等.冬春谧阳方对高脂血症患者PPARγ/ANGPTL受体配体的影响[J].陕西中医,2023,(11):1537.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.009]
ZHOU Fang,CHEN Wenming,CHEN Xinyu,et al.Effect of Dongchun Miyang decoction on serum PPARγ/ANGPTL receptor ligand in patients with hyperlipidemia[J].,2023,(12):1537.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.009]
[7]刘美之,王俊林,边爱忠,等.从中医痰湿体质论治高脂血症研究进展[J].陕西中医,2024,(5):719.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.034]
[8]李春晓,李怀臣.茵陈蒿汤调控Nrf-2/HO-1通路对慢性阻塞性肺疾病大鼠气道重塑的影响[J].陕西中医,2024,(8):1031.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.005]
LI Chunxiao,LI Huaichen.Effect of Yinchenhao decoction on airway remodeling in rats with chronic obstructive pulmonary disease by regulating the Nrf-2/HO-1 pathway[J].,2024,(12):1031.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.005]